The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice

Biochemical Pharmacology

Volumn 67, Issue 4, 2004, Pages 735-741

  Heinzen, Erin L ^a   Pollack, Gary M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Morphine; Nitric oxide; NOS deficient mice; Tolerance

Indexed keywords

ARGININE; ISOPROTEIN; MORPHINE SULFATE; NITRIC OXIDE SYNTHASE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG RESPONSE; DRUG TOLERANCE; ENDOTHELIUM; EXPERIMENT; HEAT; MALE; MEASUREMENT; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROVOCATION TEST; TAIL FLICK TEST; TIME;

EID: 1642452649     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.08.046     Document Type: Article

References (28)

1. Babey A.M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1994;1463-1470.
2. Moncada S., Higgs E.A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
3. Feelisch JB, Stamler JS. Methods in nitric oxide research. Chichester: Wiley; 1996.
4. Bhargava H.N., Sharma S.S., Bian J.T. Evidence for a role of N-methyl-D-aspartate receptors in L-arginine-induced attenuation of morphine antinociception. Brain Res. 782:1998;314-317.
5. Rauhala P., Idanpaan-Heikkila J.J., Tuominen R.K., Mannisto P.T. N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 259:1994;57-64.
6. Xu J.Y., Hill K.P., Bidlack J.M. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance. J. Pharmacol. Exp. Ther. 284:1998;196-201.
7. Marek P., Ben-Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
8. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 68:1996;229-237.
9. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5162-5166.
10. Ben-Eliyahu S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
11. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
12. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
13. Pataki I, Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine action in mice. Further evidence that nitric oxide modifies acute and chronic morphine action in mice. Eur J Pharmacol 1998;357:157-62.
14. Bhargava H.N., Bian J.T., Kumar S. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. J. Pharmacol. Exp. Ther. 281:1997;707-712.
15. Bhargava H.N., Cao Y.J., Zhao G.M. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice. Peptides. 18:1997;797-800.
16. Ozek M., Uresin Y., Gungor M. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci. 72:2003;1943-1951.
17. Homayoun H., Khavandgar S., Ejtemaei Mehr S., Namiranian K., Dehpour A.R. The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. Behav. Pharmacol. 14:2003;121-127.
18. Kolesnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8220-8225.
19. Wolff D.J., Gribin B.J. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents. Arch. Biochem. Biophys. 311:1994;300-306.
20. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
21. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., Smithies O. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13176-13181.
22. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
23. Ogura T., Yokoyama T., Fujisawa H., Kurashima Y., Esumi H. Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system. Biochem. Biophys. Res. Commun. 193:1993;1014-1022.
24. Huang P.L., Fishman M.C. Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J. Mol. Med. 74:1996;415-421.
25. Zamir N., Stegal M. Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats. Brain Res. 160:1979;170-173.
26. Levy G. Relationship between elimination rate of drugs and rate of decline of their pharmacological effect. J. Pharm. Sci. 53:1964;342-347.
27. Taylor D.A., Fleming W.W. Unifying perspectives in the mechanisms underlying the development of tolerance and physical dependence to opioids. J. Pharmacol. Exp. Ther. 297:2001;11-18.
28. Liu J., Anand K.J.S. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res. Rev. 38:2001;1-19.